Skip to main content
Photo of  Alison Weiss, PhD

Alison Weiss, PhD

Professor (F3)

COM Mol Gen Weiss Lab

Education/Credentials
  • A.B.: Washington University
  • M.S.: University of Washington
  • Ph.D.: Stanford University
Research Interests

Whooping cough remains an unconquered disease, worldwide. Developing nations simply do not have the resources to vaccinate their children. Very little disease is seen in the United States, and this is entirely due to the use of the whole-cell vaccine. How...

Contact Information
  • Office 2254 Medical Sciences Building
  • 231 Albert Sabin Way
  • Cincinnati, Ohio 45267
  • Office (513)558-2820
  • Email alison.weiss@uc.edu

Peer Reviewed Publications

Karve, SS and AA Weiss 2014. Glycolipid Binding Preferences of Shiga Toxin Variants PLoS ONE, 9(7): e101173 ,

Gaston MA, Pellino CA, Weiss AA 2013. Failure of Manganese to Protect from Shiga Toxin. PLoS ONE , 8(7): e69823 ,

Lee, C., M.A. Gaston, A.A. Weiss, and P. Zhang 2013. . Colorimetric viral detection based on sialic acid stabilized gold nanoparticles. Biosensor. Bioelectronic, , 236

Millen SH, Schneider OD, Miller WE, Monaco JJ, Weiss AA 2013. Pertussis Toxin B-Pentamer Mediates Intercellular Transfer of Membrane Proteins and Lipids. PLoS ONE , 8(9): ,

Yosief, H.O., A.A. Weiss and S.S. Iyer 2013. Capture of uropathogenic Escherichia coli using synthetic glycan ligands specific for the Pap-pilus. ChemBioChem, 14 ,

Yosief, H.O., S.S. Iyer, and A.A. Weiss 2013. Binding of Pk-trisaccharide analogs of Globotriaosylceramide to Shiga toxin variants. Infect. Immun, 81 ,

Gallegos, Karen M; Conrady, Deborah G; Karve, Sayali S; Gunasekera, Thusitha S; Herr, Andrew B; Weiss, Alison A 2012. Shiga toxin binding to glycolipids and glycans. PloS one, 7 2, e30368

Schneider, Olivia D; Millen, Scott H; Weiss, Alison A; Miller, William E 2012. Mechanistic insight into pertussis toxin and lectin signaling using T cells engineered to express a CD8?/CD3? chimeric receptor. Biochemistry, 51 20, 4126-37

Archdeacon, Michael T; Kazemi, Namdar; Romanowski, James R; Mobberley-Schuman, Paula S; Weiss, Alison A 2011. Reaming as an adjuvant to irrigation on bacterial presence and propagation: an open, cadaveric intramedullary fracture model. Journal of orthopaedic trauma, 25 6, 325-30

Fuller, Cynthia A; Pellino, Christine A; Flagler, Michael J; Strasser, Jane E; Weiss, Alison A 2011. Shiga toxin subtypes display dramatic differences in potency. Infection and immunity, 79 3, 1329-37

Conrady, Deborah G; Flagler, Michael J; Friedmann, David R; Vander Wielen, Bradley D; Kovall, Rhett A; Weiss, Alison A; Herr, Andrew B 2010. Molecular basis of differential B-pentamer stability of Shiga toxins 1 and 2. PloS one, 5 12, e15153

Flagler, Michael J; Mahajan, Sujit S; Kulkarni, Ashish A; Iyer, Suri S; Weiss, Alison A 2010. Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2. Biochemistry, 49 8, 1649-57

Kulkarni, Ashish A; Fuller, Cynthia; Korman, Henry; Weiss, Alison A; Iyer, Suri S 2010. Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2. Bioconjugate chemistry, 21 8, 1486-93

Kulkarni, Ashish A; Weiss, Alison A; Iyer, Suri S 2010. Detection of carbohydrate binding proteins using magnetic relaxation switches. Analytical chemistry, 82 17, 7430-5

Kulkarni, Ashish A; Weiss, Alison A; Iyer, Suri S 2010. Glycan-based high-affinity ligands for toxins and pathogen receptors. Medicinal research reviews, 30 2, 327-93

Millen, Scott H; Lewallen, Daniel M; Herr, Andrew B; Iyer, Suri S; Weiss, Alison A 2010. Identification and characterization of the carbohydrate ligands recognized by pertussis toxin via a glycan microarray and surface plasmon resonance. Biochemistry, 49 28, 5954-67

Schneider, Olivia D; Weiss, Alison A; Miller, William E 2009. Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4. Journal of immunology (Baltimore, Md. : 1950), 182 9, 5730-9

Conrady, Deborah G; Brescia, Cristin C; Horii, Katsunori; Weiss, Alison A; Hassett, Daniel J; Herr, Andrew B 2008. A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proceedings of the National Academy of Sciences of the United States of America, 105 49, 19456-61

Hatch, Duane M; Weiss, Alison A; Kale, Ramesh R; Iyer, Suri S 2008. Biotinylated bi- and tetra-antennary glycoconjugates for Escherichia coli detection. Chembiochem : a European journal of chemical biology, 9 15, 2433-42

Kale, Ramesh R; McGannon, Colleen M; Fuller-Schaefer, Cynthia; Hatch, Duane M; Flagler, Michael J; Gamage, Shantini D; Weiss, Alison A; Iyer, Suri S 2008. Differentiation between structurally homologous Shiga 1 and Shiga 2 toxins by using synthetic glycoconjugates. Angewandte Chemie (International ed. in English), 47 7, 1265-8

Taft, Sarah C; Weiss, Alison A 2008. Toxicity of anthrax toxin is influenced by receptor expression. Clinical and vaccine immunology : CVI, 15 9, 1330-6

Taft, Sarah C; Weiss, Alison A 2008. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor. Clinical and vaccine immunology : CVI, 15 1, 71-5

Flagler, Michael J; Strasser, Jane E; Chalk, Claudia L; Weiss, Alison A 2007. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis. Infection and immunity, 75 2, 760-5

Schneider, Olivia D; Weiss, Alison A; Miller, William E 2007. Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells. Infection and immunity, 75 8, 4040-9

Gamage, Shantini D; Patton, Angela K; Strasser, Jane E; Chalk, Claudia L; Weiss, Alison A 2006. Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine. Infection and immunity, 74 3, 1977-83

Hanson, James F; Taft, Sarah C; Weiss, Alison A 2006. Neutralizing antibodies and persistence of immunity following anthrax vaccination. Clinical and vaccine immunology : CVI, 13 2, 208-13

Watanabe, Mineo; Connelly, Beverly; Weiss, Alison A 2006. Characterization of serological responses to pertussis. Clinical and vaccine immunology : CVI, 13 3, 341-8

Mobberley-Schuman, Paula S; Weiss, Alison A 2005. Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils. Infection and immunity, 73 11, 7317-23

Gamage, Shantini D; McGannon, Colleen M; Weiss, Alison A 2004. Escherichia coli serogroup O107/O117 lipopolysaccharide binds and neutralizes Shiga toxin 2. Journal of bacteriology, 186 16, 5506-12

Gamage, Shantini D; Patton, Angela K; Hanson, James F; Weiss, Alison A 2004. Diversity and host range of Shiga toxin-encoding phage. Infection and immunity, 72 12, 7131-9

Millen, Scott H; Bernstein, David I; Connelly, Beverly; Ward, Joel I; Chang, Swei-Ju; Weiss, Alison A 2004. Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells. Infection and immunity, 72 1, 615-20

Rambow-Larsen, Amy A; Weiss, Alison A 2004. Temporal expression of pertussis toxin and Ptl secretion proteins by Bordetella pertussis. Journal of bacteriology, 186 1, 43-50

Schaeffer, Lyndsay M; McCormack, Francis X; Wu, Huixing; Weiss, Alison A 2004. Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Infection and immunity, 72 12, 7124-30

Schaeffer, Lyndsay M; McCormack, Francis X; Wu, Huixing; Weiss, Alison A 2004. Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. Journal of immunology (Baltimore, Md. : 1950), 173 3, 1959-65

Weiss, Alison A; Patton, Angela K; Millen, Scott H; Chang, Swei-Ju; Ward, Joel I; Bernstein, David I 2004. Acellular pertussis vaccines and complement killing of Bordetella pertussis. Infection and immunity, 72 12, 7346-51

Barnes, Michael G; Weiss, Alison A 2003. Activation of the complement cascade by Bordetella pertussis. FEMS microbiology letters, 220 2, 271-5

Gamage, Shantini D; Strasser, Jane E; Chalk, Claudia L; Weiss, Alison A 2003. Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin. Infection and immunity, 71 6, 3107-15

Mobberley-Schuman, Paula S; Connelly, Beverly; Weiss, Alison A 2003. Phagocytosis of Bordetella pertussis incubated with convalescent serum. The Journal of infectious diseases, 187 10, 1646-53

Stenson, Trevor H; Patton, Angela K; Weiss, Alison A 2003. Reduced glutathione is required for pertussis toxin secretion by Bordetella pertussis. Infection and immunity, 71 3, 1316-20

Barnes, Michael G; Weiss, Alison A 2002. Growth phase influences complement resistance of Bordetella pertussis. Infection and immunity, 70 1, 403-6

Rambow-Larsen, Amy A; Weiss, Alison A 2002. The PtlE protein of Bordetella pertussis has peptidoglycanase activity required for Ptl-mediated pertussis toxin secretion. Journal of bacteriology, 184 11, 2863-9

Stenson, Trevor H; Weiss, Alison A 2002. DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis. Infection and immunity, 70 5, 2297-303

Barnes, M G; Weiss, A A 2001. BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition. Infection and immunity, 69 5, 3067-72

Schaeffer, L M; Weiss, A A 2001. Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes. Infection and immunity, 69 12, 7635-41

Craig-Mylius, K A; Stenson, T H; Weiss, A A 2000. Mutations in the S1 subunit of pertussis toxin that affect secretion. Infection and immunity, 68 3, 1276-81

Craig-Mylius, K A; Weiss, A A 2000. Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis. Antimicrobial agents and chemotherapy, 44 5, 1383-6

Lenz, D H; Weingart, C L; Weiss, A A 2000. Phagocytosed Bordetella pertussis fails to survive in human neutrophils. Infection and immunity, 68 2, 956-9

Weingart, C L; Keitel, W A; Edwards, K M; Weiss, A A 2000. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infection and immunity, 68 12, 7175-9

Weingart, C L; Mobberley-Schuman, P S; Hewlett, E L; Gray, M C; Weiss, A A 2000. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils. Infection and immunity, 68 12, 7152-5

Weingart, C L; Weiss, A A 2000. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infection and immunity, 68 3, 1735-9

Craig-Mylius, K A; Weiss, A A 1999. Mutants in the ptlA-H genes of Bordetella pertussis are deficient for pertussis toxin secretion. FEMS microbiology letters, 179 2, 479-84

Weingart, C L; Broitman-Maduro, G; Dean, G; Newman, S; Peppler, M; Weiss, A A 1999. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infection and immunity, 67 8, 4264-7

Weiss, A A; Mobberley, P S; Fernandez, R C; Mink, C M 1999. Characterization of human bactericidal antibodies to Bordetella pertussis. Infection and immunity, 67 3, 1424-31

Fernandez, R C; Weiss, A A 1998. Serum resistance in bvg-regulated mutants of Bordetella pertussis. FEMS microbiology letters, 163 1, 57-63

Rambow, A A; Fernandez, R C; Weiss, A A 1998. Characterization of BrkA expression in Bordetella bronchiseptica. Infection and immunity, 66 8, 3978-80

Fernandez, R C; Weiss, A A 1996. Susceptibilities of Bordetella pertussis strains to antimicrobial peptides. Antimicrobial agents and chemotherapy, 40 4, 1041-3

Fernandez, R C; Weiss, A A 1995. Cloning and sequencing of the Bordetella pertussis cpn10/cpn60 (groESL) homolog. Gene, 158 1, 151-2

Fernandez, R C; Weiss, A A 1994. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infection and immunity, 62 11, 4727-38

Walker, K E; Weiss, A A 1994. Characterization of the dermonecrotic toxin in members of the genus Bordetella. Infection and immunity, 62 9, 3817-28

Hewlett, E L; Gray, M C; Ehrmann, I E; Maloney, N J; Otero, A S; Gray, L; Allietta, M; Szabo, G; Weiss, A A; Barry, E M 1993. Characterization of adenylate cyclase toxin from a mutant of Bordetella pertussis defective in the activator gene, cyaC. The Journal of biological chemistry, 268 11, 7842-8

Ehrmann, I E; Weiss, A A; Goodwin, M S; Gray, M C; Barry, E; Hewlett, E L 1992. Enzymatic activity of adenylate cyclase toxin from Bordetella pertussis is not required for hemolysis. FEBS letters, 304 1, 51-6

Barry, E M; Weiss, A A; Ehrmann, I E; Gray, M C; Hewlett, E L; Goodwin, M S 1991. Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. Journal of bacteriology, 173 2, 720-6

Stibitz, S; Weiss, A A; Falkow, S 1988. Genetic analysis of a region of the Bordetella pertussis chromosome encoding filamentous hemagglutinin and the pleiotropic regulatory locus vir. Journal of bacteriology, 170 7, 2904-13

Pearson, R D; Symes, P; Conboy, M; Weiss, A A; Hewlett, E L 1987. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. Journal of immunology (Baltimore, Md. : 1950), 139 8, 2749-54

Cronin, M J; Evans, W S; Rogol, A D; Weiss, A A; Thorner, M O; Orth, D N; Nicholson, W E; Yasumoto, T; Hewlett, E L 1986. Prokaryotic adenylate cyclase toxin stimulates anterior pituitary cells in culture. The American journal of physiology, 251 2 Pt 1, E164-71

Weiss, A A; Hewlett, E L 1986. Virulence factors of Bordetella pertussis. Annual review of microbiology, 40 , 661-86

Hewlett, E L; Weiss, A A; Crane, J K; Pearson, R D; Anderson, H J; Myers, G A; Evans, W S; Hantske, L L; Kay, H D; Cronin, M J 1985. Bordetella extracytoplasmic adenylate cyclase: actions as a bacterial toxin. Developments in biological standardization, 61 , 21-6

Steinman, L; Weiss, A; Adelman, N; Lim, M; Oehlert, J; Zuniga, R; Hewlett, E; Falkow, S 1985. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin. Developments in biological standardization, 61 , 439-46

Steinman, L; Weiss, A; Adelman, N; Lim, M; Zuniga, R; Oehlert, J; Hewlett, E; Falkow, S 1985. Pertussis toxin is required for pertussis vaccine encephalopathy. Proceedings of the National Academy of Sciences of the United States of America, 82 24, 8733-6

Weiss, A A; Hewlett, E L; Myers, G A; Falkow, S 1985. Genetic studies of the molecular basis of whooping cough. Developments in biological standardization, 61 , 11-9

Weiss, A A; Falkow, S 1984. Genetic analysis of phase change in Bordetella pertussis. Infection and immunity, 43 1, 263-9

Weiss, A A; Hewlett, E L; Myers, G A; Falkow, S 1984. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. The Journal of infectious diseases, 150 2, 219-22

Weiss, A A; Falkow, S 1983. Transposon insertion and subsequent donor formation promoted by Tn501 in Bordetella pertussis. Journal of bacteriology, 153 1, 304-9

Weiss, A A; Hewlett, E L; Myers, G A; Falkow, S 1983. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infection and immunity, 42 1, 33-41

Weiss, A A; Falkow, S 1982. Plasmid transfer to Bordetella pertussis: conjugation and transformation. Journal of bacteriology, 152 1, 549-52

Temple L.M.;Weiss A.A.;Walker K.E.;Barnes H.J.;Christensen V.L.;Miyamoto D.M.;Shelton C.B.;Orndorff P.E. 12-01-1998. Bordetella avium virulence measured in vivo and in vitro Infection and Immunity, 66 11, 5244-5251

Denko N.; Hudson K.; Lieberman M.; Oswald E.; Schwab E.; Weiss A. 11-01-1996. Megakaryocytic cell line-specific hyperploidy by cytotoxic necrotizing factor bacterial toxins Blood, 88 9, 3465-3473

Pradhan S.;Pellino C.;MacMaster K.;Coyle D.;Weiss A. 09-29-2016. Shiga toxin mediated neurologic changes in murine model of disease Frontiers in Cellular and Infection Microbiology, 6 SEP,

Millen S.H.;Watanabe M.;Komatsu E.;Yamaguchi F.;Nagasawa Y.;Suzuki E.;Monaco H.;Weiss A.A. 09-16-2015. Single amino acid polymorphisms of pertussis toxin subunit S2 (PtxB) affect protein function PLoS ONE, 10 9,

Millen S.;Schneider O.;Miller W.;Monaco J.;Weiss A. 09-03-2013. Pertussis Toxin B-Pentamer Mediates Intercellular Transfer of Membrane Proteins and Lipids PLoS ONE, 8 9,

McGannon C.;Fuller C.;Weiss A. 09-01-2010. Different classes of antibiotics differentially influence shiga toxin production Antimicrobial Agents and Chemotherapy, 54 9, 3790-3798

Gaston M.;Pellino C.;Weiss A. 07-16-2013. Failure of Manganese to Protect from Shiga Toxin PLoS ONE, 8 7,

Karve S.;Weiss A. 07-01-2014. Glycolipid binding preferences of shiga toxin variants PLoS ONE, 9 7,

Karve S.;Pradhan S.;Ward D.;Weiss A. 06-01-2017. Intestinal organoids model human responses to infection by commensal and Shiga toxin producing Esche PLoS ONE, 12 6,

Pellino C.;Karve S.;Pradhan S.;Weiss A. 06-01-2016. AB<inf>5</inf>preassembly is not required for Shiga toxin activity Journal of Bacteriology, 198 11, 1621-1630

Schneider O.;Millen S.;Weiss A.;Miller W. 05-22-2012. Mechanistic insight into pertussis toxin and lectin signaling using t cells engineered to express a Biochemistry, 51 20, 4126-4137

Komatsu E.;Yamaguchi F.;Abe A.;Weiss A.;Watanabe M. 05-01-2010. Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular p Clinical and Vaccine Immunology, 17 5, 807-812

Fisher J.; Kim K.; Kuzmenko A.; McCormack F.; Schaffer L.; Wan S.; Weiss A.; Wu H. 05-01-2003. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane perm The Journal of clinical investigation, 111 10, 1589-1602

Lee C.;Gaston M.;Weiss A.;Zhang P. 04-05-2013. Colorimetric viral detection based on sialic acid stabilized gold nanoparticles Biosensors and Bioelectronics, 42 1, 236-241

Hoppe J.; WeiƟ A. 04-01-1987. Recovery of Bordetella pertussis from four kinds of swabs European Journal of Clinical Microbiology, 6 2, 203-205

Gallegos K.;Conrady D.;Karve S.;Gunasekera T.;Herr A.;Weiss A. 02-13-2012. Shiga toxin binding to glycolipids and glycans PLoS ONE, 7 2,

Lee C.;Wang P.;Gaston M.;Weiss A.;Zhang P. 01-01-2017. Plasmonics-based detection of virus using sialic acid functionalized gold nanoparticles Methods in Molecular Biology, 1571 , 109-116

Murdock R.C.;Gallegos K.M.;Hagen J.A.;Kelley-Loughnane N.;Weiss A.A.;Papautsky I. 01-01-2017. Development of a point-of-care diagnostic for influenza detection with antiviral treatment effective Lab on a Chip, 17 2, 332-340

Yosief H.O.;Weiss A.A.;Iyer S.S. 01-01-2013. Capture of Uropathogenic E. coli by Using Synthetic Glycan Ligands Specific for the Pap-Pilus ChemBioChem, 14 2, 251-259

Weiss A.;Iyer S. 01-01-2007. Glycomics aims to interpret the third molecular language of cells Microbe, 2 10, 489-497

Wu H.;Kuzmenko A.;Wan S.;Schaffer L.;Weiss A.;Fisher J.;Kim K.;McCormack F. 01-01-2003. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane perm Journal of Clinical Investigation, 111 10, 1589-1602

Ehrmann I.;Weiss A.;Goodwin M.;Gray M.;Barry E.;Hewlett E. 01-01-1993. Erratum: Enzymatic activity of adenylate cyclase toxins from Bordetella pertussis is not required fo FEBS Letters, 320 1, 86

Melton A.;Weiss A. 01-01-1993. Characterization of environmental regulators of Bordetella pertussis Infection and Immunity, 61 3, 807-815

Weiss A.;Johnson F.;Burns D. 01-01-1993. Molecular characterization of an operon required for pertussis toxin secretion Proceedings of the National Academy of Sciences of the United States of America, 90 7, 2970-2974

Goodwin M.S.M.;Weiss A.A. 01-01-1990. Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infe Infection and Immunity, 58 10, 3445-3447

Ewanowich C.;Melton A.;Weiss A.;Sherburne R.;Peppler M. 01-01-1989. Invasion of HeLa 229 cells by virulent Bordetella pertussis Infection and Immunity, 57 9, 2698-2704

Melton A.;Weiss A. 01-01-1989. Environmental regulation of expression of virulence determinants in Bordetella pertussis Journal of Bacteriology, 171 11, 6206-6212

Weiss A.;Melton A.;Walker K.;Androaos-Selim C.;Meidl J. 01-01-1989. Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regu Infection and Immunity, 57 9, 2674-2682

Weiss A.;St. Mary Goodwin M. 01-01-1989. Lethal infection by Bordetella pertussis mutants in the infant mouse model Infection and Immunity, 57 12, 3757-3764

Hoppe J.; Weiss A.; Worz S. 01-01-1988. Failure of charcoal-horse-blood broth with cephalexin to significantly increase rate of Bordetella i Journal of Clinical Microbiology, 26 6, 1248-1249

Rich R.; Tuomanen E.; Weiss A. 01-01-1985. Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia Developments in Biological Standardization, VOL. 61 , 197-204

Tuomanen E.; Weiss A. 01-01-1985. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial c Journal of Infectious Diseases, 152 1, 118-125

Steinman L.;Weiss A.;Adelman N.;Lim M.;Zuniga R.;Oehlert J.;Hewlett E.;Falkow S. 01-01-1985. Pertussis toxin is required for pertussis vaccine encephalopathy Proceedings of the National Academy of Sciences of the United States of America, 82 24, 8733-8736

Directory Search

CONTACT US

Molecular Genetics, Biochemistry & Microbiology
Medical Sciences Building
231 Albert Sabin Way
PO Box 670524
Cincinnati, Ohio 45267-0524